After a long gestation, the UN drug reform experiment suffered a miscarriage. It seems the UN is not the catalyst of change but its mirror. Reformers can learn many lessons – but can also be proud of their achievements.
Criminalisation
The UN Summit on Drugs Ended Before It Began
The UN General Assembly Special Session on Drugs (UNGASS) adopted the outcome document without a debate, right before the real discussion could have started.
Drug Policy is Race Policy
Hundreds of drug reformers gathered at the “Drug Policy and the Politics of Race” event, organised at Columbia University on Sunday, to discuss how repressive drug policies affect the lives of communities of colour. Watch our videos!
Growing Disagreement at the Commission on Narcotic Drugs
While Colombia and the Czech Republic spoke up for drug policy reform at the opening day of the CND, others such as Russia or Thailand prefer the status quo and oppose any changes.
Norway Promotes Forced Drug Treatment Under a False Flag
Norway claims to have a progressive drug policy – but does it really? Our guest author from NORML Norway thinks otherwise.
The World Has Failed People Who Use Drugs
A speech delivered by Olga Szubert on behalf of the Harm Reduction International at the ongoing civil society hearing at the UN Headquarters in New York. The hearing aims to update member states in preparations for the UN General Assembly Special Session on Drugs, to be held in April.
Report on the Criminalisation of Cannabis Users in Slovenia
ONEJ, a Slovenian cannabis reform NGO, has published a report on the criminalisation of cannabis users in Slovenia – a country which will soon see its first legal supervised injection room. The report also highlights the need to reform the country's drug laws!
Cushion Effect: How do We Deal With Austerity in Drug Policy?
The consequences of the economic crisis are threatening the continuity of the integrated intervention system that characterises the “Portuguese Model”. Read what our local partner APDES is doing to preserve the country's achievments in the field of drug policy.










